Tag: chronic limb-threatening ischemia

SCAI

New analysis probes BEST-CLI trial against real-world setting data

A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Ses­sions...

End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66%...

Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint...

BEST-CLI attracts $3.3m funding injection to continue data analysis 

The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...

Positive two-year data from ALPS registry of LimFlow system published

LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialization (pDVA) system. Results were published...

When world vascular societies combined to produce new global guidelines for...

Four years ago, vascular experts from around the world were tasked with a quest to get all surgeons and providers to agree on the...